» Articles » PMID: 35819523

Schistosoma Mansoni Infection Decreases IL-33-mRNA Expression and Increases CXCL9 and CXCL10 Production by Peripheral Blood Cells

Abstract

Schistosoma mansoni infections, particularly egg antigens, induce Th2-dominant granulomatous responses accompanied by remarkable immunoregulatory mechanisms that avoid intense fibrosis. Interleukin (IL)-33 is a cytokine that stimulates the early activation of Th2 responses, and its soluble ST2 receptor (sST2) avoids granulomatous response, as well as CXCL9 and CXCL10 chemokines that have antifibrotic activity. However, in schistosomiasis, these molecules have not been suitably studied. Therefore, this study aimed to measure IL-33 and sST2 RNA, cytokines, and chemokines in peripheral blood cultures from individuals living in schistosomiasis-endemic areas. Peripheral blood cells from individuals with S. mansoni (n = 34) and non-infected individuals (n = 31) were cultured under mitogen stimulation. Supernatant chemokines and cytokines were evaluated using a cytometric bead array, and IL-33 and sST2 mRNA expression was measured using qPCR. Infected individuals showed higher levels of CXCL8, CXCL9, CXCL10, IFN-γ, TNF-α, IL-6, IL-2, IL-4, and IL-10; there was a lower expression of IL-33 mRNA and similar expression of sST2mRNA in infected than non-infected individuals. In conclusion, for the first time, we demonstrated lower IL-33mRNA expression and high levels of the antifibrotic chemokines CXCL9 and CXCL10 in schistosomiasis mansoni, which could control exacerbations of the disease in individuals from endemic areas.

Citing Articles

Prior infection protects against induced hepatic fibrosis.

El-Kady A, Altwaim S, Wakid M, Banjar A, Mohammed K, Alfaifi M Front Vet Sci. 2024; 11:1443267.

PMID: 39439825 PMC: 11494294. DOI: 10.3389/fvets.2024.1443267.


Comparative transcriptome analyses of immune responses to LPS in peripheral blood mononuclear cells from the giant panda, human, mouse, and monkey.

Li S, Li C, Chen L, Yang H, Ren X, Xu C Front Genet. 2023; 13:1053655.

PMID: 36685921 PMC: 9852843. DOI: 10.3389/fgene.2022.1053655.

References
1.
Sa Barreto A, Lacerda G, Figueiredo A, Diniz G, Gomes E, Domingues A . Evaluation of serum levels of IL-9 and IL-17 in human Schistosoma mansoni infection and their relationship with periportal fibrosis. Immunobiology. 2016; 221(12):1351-1354. DOI: 10.1016/j.imbio.2016.07.014. View

2.
Prata A, Ruiz-Guevara R, Antunes C, Marinho C, Queiroz L, Voieta I . Comparison between clinical and ultrasonographic findings in cases of periportal fibrosis in an endemic area for schistosomiasis mansoni in Brazil. Rev Soc Bras Med Trop. 2010; 43(2):129-34. DOI: 10.1590/s0037-86822010000200005. View

3.
Colley D, Secor W . Immunology of human schistosomiasis. Parasite Immunol. 2014; 36(8):347-57. PMC: 4278558. DOI: 10.1111/pim.12087. View

4.
Chuah C, Jones M, Burke M, McManus D, Gobert G . Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology. Trends Parasitol. 2014; 30(3):141-50. DOI: 10.1016/j.pt.2013.12.009. View

5.
Zhang Y, Zhang Y, Gu W, Sun B . TH1/TH2 cell differentiation and molecular signals. Adv Exp Med Biol. 2014; 841:15-44. DOI: 10.1007/978-94-017-9487-9_2. View